Drugs Containing Excipient (Inactive Ingredient) CORN OIL

Branded drugs containing CORN OIL excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	SANDIMMUNE	cyclosporine	0078-0240	CORN OIL
Novartis Pharmaceuticals Corporation	NEORAL	cyclosporine	0078-0246	CORN OIL
Rebel Distributors Corp	DELSYM	dextromethorphan polistirex	21695-517	CORN OIL
Prasco Laboratories	AMPHETAMINE EXTENDED-RELEASE ORAL SUSPENSION	amphetamine	66993-360	CORN OIL
Neos Therapeutics LP	ADZENYS ER	amphetamine	70165-003	CORN OIL

Generic drugs containing CORN OIL excipient

Company	Ingredient	NDC	Excipient
Novartis Pharmaceuticals Corporation	cyclosporine	0078-0240	CORN OIL
Novartis Pharmaceuticals Corporation	cyclosporine	0078-0246	CORN OIL
Hikma Pharmaceuticals USA Inc	ciprofloxacin	0143-9927	CORN OIL
Mylan Pharmaceuticals Inc	isotretinoin	0378-6611	CORN OIL
Honeywell Safety Products USA Inc	loperamide hcl	0498-1071	CORN OIL

Market Dynamics and Financial Trajectory for Corn Oil as a Pharmaceutical Excipient

Last updated: March 30, 2026

What is the Role of Corn Oil in Pharmaceutical Industry?

Corn oil is a plant-based lipid derived from the germ of maize (Zea mays). It is classified primarily as a nutritional supplement but has gained prominence as an excipient in pharmaceutical formulations, mainly as an emollient, carrier, or diluent. Corn oil's compatibility with various drug delivery routes, including oral and topical, is notable due to its inertness, safety profile, and availability.

Market Size and Growth Projections

The global pharmaceutical excipients market was valued at approximately USD 5.3 billion in 2021. Corn oil accounts for an estimated 3-4% of this market, translating to roughly USD 160 million to USD 212 million in 2021.

Forecasts project a compound annual growth rate (CAGR) of about 6.5% between 2022 and 2028, driven by increasing demand for natural excipients amid the expansion of generic and biosimilar drug markets.

Historical Revenue and Growth Trends

Year	Estimated Market Share (USD Million)	Compound Annual Growth Rate (2022-2028)
2021	USD 160-212	N/A
2022	USD 170-226	6.5%
2023	USD 180-240	6.5%
2024	USD 193-257	6.5%
2025	USD 206-276	6.5%
2026	USD 220-294	6.5%
2027	USD 235-315	6.5%
2028	USD 251-336	6.5%

Drivers of Market Growth

Shift Toward Natural Excipients

Consumer preference for natural, plant-derived excipients increases demand for corn oil. Regulatory agencies, such as the FDA and EMA, favor excipients with proven safety profiles and sustainable sourcing.

Expansion of Biopharmaceuticals and Generic Drugs

The rise in biologics and generics requires excipients compatible with diverse formulations. Corn oil's stability and inertness make it suitable for parenteral and topical applications.

Supply Chain and Cost Factors

Corn oil's widespread availability and lower manufacturing costs compared to other lipid excipients boost its adoption. Variability in prices is influenced by agricultural trends and commodity markets.

Competitive Landscape

Major players include:

• Archer Daniels Midland Company (ADM)
• Cargill, Inc.
• Bunge Limited
• Wilmar International
• Local and regional suppliers in India, China, and Latin America

These companies focus on securing raw material supply chains, establishing processing facilities, and developing specialized grades for pharmaceutical applications.

Regulatory and Quality Standards

Corn oil used as an excipient must comply with standards such as USP <2040> for vegetable oils, and other pharmacopeial monographs. Quality factors include purity, free from contaminants like pesticides, heavy metals, and foreign impurities.

Manufacturers often pursue certifications such as ISO 9001, ISO 22000, and current Good Manufacturing Practice (cGMP) compliance to meet pharmaceutical standards.

Challenges and Risks

• Agricultural paper fluctuations affecting raw material costs
• Variability in oil quality based on source and extraction method
• Regulatory hurdles in certain markets requiring extensive safety validation

Financial Trajectory and Investment Insights

Investments are primarily directed toward optimizing extraction processes, developing specialty grades, and expanding manufacturing capacity to meet rising demand. Horizontal integration with agricultural suppliers and vertical integration within processing facilities enhances supply security.

Although market penetration is growing, corn oil remains a niche within the broader excipient market, emphasizing premium pricing driven by quality standards and certifications rather than volume.

Key Takeaways

• The global corn oil excipient segment is approximately USD 160-212 million as of 2021, with potential to reach USD 336 million by 2028 at a CAGR of 6.5%.
• Natural and sustainable sourcing strategies are critical for growth.
• Market expansion hinges on regulatory acceptance, supply chain reliability, and technological advancements in extraction and purification.
• Major players are consolidating supply chains and investing in quality certifications to meet pharmaceutical standards.
• Price volatility and raw material variability pose ongoing risks.

FAQs

What are the advantages of using corn oil as a pharmaceutical excipient?
It is inert, biocompatible, and derived from renewable sources, making it suitable for various formulations, including injectables, topical applications, and oral drugs.

Are there regulatory concerns surrounding corn oil use as an excipient?
Yes. It must meet pharmacopeial standards for purity, free from contaminants. Validation may be needed for new formulations or markets with specific safety requirements.

How does corn oil compare to other lipid excipients?
Compared to soy oil or avocado oil, corn oil has a more consistent supply, lower production costs, and established safety data, making it advantageous for cost-sensitive applications.

What are the key factors influencing prices of corn oil in pharma?
Crop yields, weather conditions, global commodity prices, and extraction complexity influence the pricing and availability.

What future technological developments could impact the market?
Innovations in refining, extraction, and purification processes will enhance purity, reduce costs, and expand uses in specialized drug delivery systems.

---

References

[1] MarketsandMarkets. (2022). Pharmaceutical Excipients Market by Type, Source, Formulation, Functionality, and Region—Forecast to 2028.
[2] USP. (2020). <2040> Vegetable Oils. United States Pharmacopeia.
[3] Grand View Research. (2021). Excipients Market Size, Share & Trends Analysis Report.
[4] USDA. (2021). Corn and Corn Product Prices. United States Department of Agriculture.